ATF3 and gastric cancer: Notably, ATF3 has been shown to increase the sensitivity of gastric cancer cells to cisplatin by promoting ferroptosis by inhibiting Nrf2/Keap1/xCT signaling [39], but the role of ATF3 in inducing cardiotoxicity through ferroptosis is still unclear.